The formation of native disulphide bonds is an essential event in the folding and maturation of proteins entering the secretory pathway. For native disulphides to form efficiently an oxidative pathway is required for disulphide bond formation and a reductive pathway is required to ensure isomerisation of non-native disulphide bonds.
Introduction
The endoplasmic reticulum (ER) provides an environment that allows the oxidative folding and post-translational modification of proteins entering the secretory pathway. The compartmentalisation of the ER away from the cytosol allows the correct redox conditions to be established (1) , which in turn enables a distinct set of folding catalysts to facilitate the formation of native disulphide bonds. A growing family of ER oxidoreductases is thought to be responsible for catalysing the formation, isomerisation and reduction of disulphide bonds (2) . These oxidoreductases contain active sites homologous to the active site found in the cytosolic reductase thioredoxin, characterised by a pair of cysteine residues (CxxC)
that shuttle between the disulphide and dithiol form (3) . The reactions that these enzymes catalyse require the individual active sites to be maintained in either the oxidised disulphide form, for disulphide bond formation, or the reduced dithiol form, for isomerisation or reduction of disulphide bonds (4) . How the active sites are maintained in either their reduced or oxidised state and how the ER maintains an environment conducive to disulphide bond formation, isomerisation and reduction has been the subject of intense speculation over the past 40 years (5, 6) . Recently, components of the oxidative pathway have been identified, however we know very little about the reductive pathway even though it is clear that disulphide bond isomerisation and reduction are essential for cell viability (7) .
It is now firmly established that the oxidoreductase PDI catalyses the formation of disulphide bonds within the eukaryotic ER (8, 9) . During disulphide bond formation an intra-chain disulphide bond between the cysteine residues within the active site is able to accept two electrons from the polypeptide chain substrate resulting in the reduction of the PDI active site. Ero1p has been shown to be responsible for the oxidation of PDI in yeast, a defect in Ero1p leads to a lack of disulphide bond formation demonstrating the crucial role played by Ero1p in the oxidative folding pathway (5, 6) . There is growing evidence to suggest that Ero1p is an FADdependent oxidase that is able to pass electrons from PDI to the ultimate electron acceptor oxygen (10) . However, Ero1p can also catalyse the oxidation of PDI under anaerobic conditions suggesting the possibility that alternative electron acceptors could substitute for oxygen under these conditions (11) .
Although a clear mechanism exists to oxidise PDI, in mammalian cells most of the ER oxidoreductases, including PDI appear to be in a predominantly reduced form at steady state (12) . This would suggest that a pathway exists to maintain these proteins in a reduced state within the cell. That PDI is predominantly reduced in mammalian cells contrasts with the situation in yeast where PDI is clearly predominantly oxidised shown to act as a reductase, at least in vitro, to allow the breaking of non-native disulphide bonds within MHC-class I heavy chain (13) . Hence there is a requirement for both an oxidative pathway for disulphide bond formation and a reductive pathway to allow reduction and isomerisation of non-native disulphides and for these pathways to co-exist in the same intra-cellular compartment.
The mechanism for maintaining ER oxidoreductases in a reduced state could involve a protein-mediated process such as exists in the E.coli periplasm where DsbD maintains the main enzyme catalysing disulphide isomerisation DsbC in a reduced state (14) . Alternatively a glutathione buffer may be involved, eliminating the requirement for a separate protein-mediated pathway for their reduction. Maintaining a pool of GSH within the ER could be brought about by continuous transport from the cytosol where glutathione reductase maintains a high concentration of GSH. Indeed some evidence exists to suggest the presence of a transport system that allows the selective passage of GSH rather than GSSG (15) . Also, elimination of glutathione from yeast cells by removal of the enzyme involved in the first step of synthesis, γglutamylcysteine synthetase, did not prevent disulphide bond formation but did render the cells more prone to hyperoxidation, suggesting a direct or indirect role for glutathione in maintaining a redox balance in the yeast ER (16) . Hence the possibility remains that reduction of ER oxidoreductases can be bought about either directly by glutathione or by a separate enzyme catalysed pathway.
To address this point we have chosen to study the folding and disulphide bond formation of human tissue type plasminogen (tPA). This protein contains 17 disulphide bonds and is secreted from recombinant cell lines as a mixture of two glycoforms that differ in their extent of core N-linked glycosylation. We have previously shown that conditions preventing disulphide bond formation, such as addition of the reducing agent DTT to culture medium of living cells, lead to complete glycosylation of a sequon that would otherwise undergo variable glycosylation in untreated cells (17) . The extent of glycosylation of tPA is therefore intimately linked to the rate of protein folding and disulphide bond formation. The close temporal relationship between glycosylation and folding of tPA allows us to evaluate the affect of altering the redox conditions on both the rate of disulphide bond formation and also the rate of protein folding. Here we present evidence establishing that a rate-limiting step in the oxidative pathway and protein folding is the oxidation of PDI. We also show that a high concentration of intra-cellular glutathione is required to ensure the formation of native disulphide bonds.
6 stably transfected cells were maintained in the selection growth medium and overexpression of Ero1-L±myc was examined by Western blot analysis.
Immunofluorescence
Cells were grown on coverslips to 50-70% confluency, washed twice in PBS and fixed in methanol for 10 minutes at -20 o C followed by a brief rehydration with PBS. were viewed on a Leica confocal microscope and images captured using a chargecoupled camera.
Western Blotting
The proteins separated by SDS-PAGE were transferred electrophoretically from the gels on to a nitrocellulose membrane. Blots were blocked in TTBS (100mM TrisHCl pH 7.5, 0.9% w/v NaCl, 0.1% v/v Tween 80) containing 3% (w/v) milk followed by incubation for 1h. in the primary antibody, rabbit anti-myc polyclonal antibody (Santa Cruz Biotechnology) or anti-PDI antibody (31), diluted to 1:500 in TTBS buffer. Blots were then washed three times for 10 minutes each in TTBS and incubated with 1:1000 dilution of goat anti-rabbit IgG-HRP (DAKO), in TTBS, for 1 h. After washing three times for 10 minutes each in TTBS, the membranes were treated with Super Signal West Pico chemiluminescent substrate (Pierce) for 5 minutes. All incubations were carried out at room temperature and the proteins were visualized by exposure to Fuji Medical X-ray film.
Radiolabelling and Immunoisolation.
For pulse chase experiments, 2 × 10 6 cells per 6 cm dish were washed twice with pre-warmed methionine-and cysteine-free DMEM (Sigma), and then pre- All samples, reduced and non-reduced, were boiled for 5 mins prior to electrophoresis. Samples were resolved by SDS-PAGE and visualized by either autoradiography using Kodak Biomax MR film or phosphorimage analysis using a Fuji Film Bas 1800 phosphorimager.
Glutathione assays
Total glutathione levels were measured using the DTNB [5, 5'-dithiobis(2-nitrobenzoic acid), Sigma]-GSSG reductase recycling assay (32) . CHO cells (2 × 10 6 ) were harvested by trypsinisation and cell pellet was lysed in 100 µl of ice cold 8 mM HCl / 1.3 % 5-sulfosalicylic acid (SSA, Sigma) by agitating with glass beads. The lysate was incubated on ice for 30 minutes. Glass beads, precipitated protein and cell debris was removed by centrifugation at 12,000g for 5 minutes. Total glutathione was measured by adding 10 µl of the lysate to 1 ml assay mixture pre-warmed to 30 0 C in a spectrophotometer cuvette. GSSG reductase was then added with mixing to initiate the assay and change in absorbance at 405 nm was measured over 4 minutes. Standard curves were generated using 0.5 -4 nmol GSH solubilised in 8 mM HCl / 1.3 % SSA.
PDI redox state
The in vivo redox state of PDI was assayed by modification with the thiol -reactive reagent acetamido-maleimidylstilbene-disulphonic acid AMS (Molecular Probes).
Cells were incubated for 10 min at 37°C with or without DTT (5 mM) or 4,4'dithiodipyridine (0.5 mM). At the end of the incubation period, the cells were transferred to ice and washed twice with ice cold phosphate-buffered saline (PBS) containing 20mM NEM to minimise disulphide bond rearrangements. The cells were lysed in 1 ml of lysis buffer (without NEM) for 10 minutes on ice. Cell lysates were centrifuged at 12,000g for 20 minutes to remove insoluble material. The supernantant was transferred into a fresh tube, 1% SDS and 10mM TCEP was added to all the samples. Samples were boiled for 2 min, cooled and treated with 25 mM AMS for 60 min at room temperature, in the dark.
Results

Overexpression of Ero1-L± leads to enhanced oxidative protein folding
Our initial studies focused on the consequence of overexpressing Ero1 on the ability of tPA to form disulphide bonds, fold correctly and be secreted. Our approach was to generate stable cell-lines expressing both t-PA and wild type Ero1 or Ero1 containing single cysteine point mutations known to compromise function (18, 19) . A indicates the formation of intra-chain disulphide bonds as previously described for the endogenous protein (19) . Some higher molecular weight bands can also be seen when the cell lysate was separated under non-reducing conditions. These higher molecular weight bands are likely to be mixed disulphides between exogenously expressed Ero1-L± and endogenous PDI, as characterised previously (12) . No such high molecular weight bands were seen with either cysteine mutants demonstrating their inability to form functional mixed disulphides with PDI ( Fig 2B, lanes 2-10) . Thus, at 1mM DTT no disulphide bonds were formed as no faster migrating protein was seen when the sample was run under non-reducing conditions. In addition the reduction of proteins within the cell with higher concentrations of DTT also caused a slight decrease in mobility of the protein when run under reducing conditions ( Fig. 2A lanes [8] [9] [10] . This is due to full alkylation by NEM of the 34-cysteine residues in tPA when the protein is reduced and is a further indication of the lack of disulphide bond formation at these concentrations of DTT.
In the cell-line overexpressing Ero1-L± the tPA synthesised was more resistant to the effects of reduction with DTT. This resistance is apparent both by the presence of variably glycosylated tPA at DTT concentrations as high as 1mM and a lack of full reduction of disulphide bonds at 2mM DTT (Fig. 2B , middle panel). Hence overexpression of Ero1 leads to formation of disulphide bonds at higher DTT concentrations indicating that Ero1 can act as an oxidase and can function in the presence of reducing agents. Additionally the ability to form disulphide bonds corresponds to an ability to also fold into a conformation that restricts glycosylation at higher concentrations of DTT, again highlighting the intimate link between disulphide bond formation and protein folding.
The ability of cysteine mutants of Ero1 to bring about a similar effect was also investigated. Mammalian Ero1 contains 14 cysteine residues of which three (Cys 391, 394 and 397) have been shown, by single point mutation, to be involved in either stabilisation of structure or enzymatic function (12, 19 ). An analysis of single cysteine mutations has also been carried out with yeast Ero1 and four cysteine residues (Cys100, Cys105, Cys352 and Cys 355) were found to be absolutely required for function (18) . These correspond to Cys99, Cys104, Cys394 and Cys397 in the human protein. We created two Ero1 cysteine mutants with mutation in cys99 or both cys99
and cys394 and prepared separate stable cell-lines expressing these proteins (Fig.   1A ). Both the cell-line expressing Ero1-cys99 ( Fig. 2A An increase in the intensity of tPA immunoisolated during the chase period after labelling in the presence of DTT was observed at early time points in both cell lines ( Fig. 3A and B) . This could reflect a lack of protein synthesis inhibition by cycloheximide. However, this is unlikely to be the case as only fully glycosylated tPA was detected during the chase and any protein synthesised during the chase would be variably glycosylated as the redox conditions within the ER are restored rapidly (24). Affinity of the polyclonal antibody for reduced and non-reduced tPA was determined (results not shown) and it was found that only 35% of the tPA immunoisolated from the non-reducing sample was precipitated from the reducing sample, demonstrating that the antibody has a reduced affinity for non-disulphide bonded tPA. Thus, the increase in the intensity of immunoisolated tPA at early time points during the chase period after DTT treatment indicates post-translational folding and disulphide formation of tPA during this period.
The ability to accelerate the oxidation of tPA after treatment with DTT could lead to the formation of native or non-native disulphide bonds. If non-native disulphide bonds were formed then the acceleration in rate of disulphide bond formation would not necessarily lead to an increase in the rate of formation of correctly folded tPA.
To investigate this point we determined whether the tPA formed after recovery from DTT treatment had undergone the conformational maturation required for its exit from the ER and secretion from the cell.
For this purpose we used the pulse chase protocol as described above, with the chase times extended to 240 minutes. After each chase time, tPA was immunoisolated from both the cell lysates and the chase medium. The immunoisolated tPA was separated under reducing conditions, to construct time courses for secretion of tPA synthesised in the presence of DTT, by the untransfected (Fig. 4A ) and Ero1-L± overexpressing ( does not effect the rate of secretion but does accelerate the formation of native disulphide bonds giving rise to tPA that is secreted from the cell. The fact that the tPA is secreted from the cell and that it has escaped the ER quality control system for glycoproteins suggests that it has folded correctly.
Glutathione is required for isomerisation of non-native disulphide bonds
Genetic evidence in yeast has demonstrated that glutathione is dispensable for (Fig. 6 A/B ).
In the BSO untreated cells, the first correctly folded tPA molecules were observed after 45-60 minutes of chase (Fig. 6A ). This result confirms our earlier observation that in the untransfected CHO-tPA cells, disulphide bond formation was complete between 30-45 minutes into the chase (Fig. 3) . In addition, we demonstrate here that a consequence of this effect on the oxidative pathway is acceleration in the rate of protein folding and the acquisition of a native structure. Hence, for tPA at least, the rate of protein folding within the cell is potentially limited by the capacity of the cell to facilitate disulphide bond formation. These results prove that the ability of proteins to adopt the correct threedimensional structure within cells can be accelerated by manipulating the level of the enzymes responsible for disulphide bond formation within the ER.
That overexpression of Ero1, a protein involved exclusively in the oxidative pathway, leads to an increase in the rate of protein folding argues that the rate limiting step in folding is the oxidation of disulphide bonds. However, this interpretation does need to be viewed with a certain degree of caution, as both in our studies and those published previously (12) conditions, a conclusion borne out by the ability of purified yeast Ero1 to catalyse the formation of disulphide bonds in the presence of 2mM GSH (10). This conclusion challenges the idea that an oxidising environment within the ER lumen is required to allow disulphide bonds to form and emphasises the importance of a specific oxidative pathway for catalysis.
The fact that PDI was more oxidised in the Ero1 overexpressing cell-line and that PDI forms mixed disulphides with Ero1 strongly suggests that it is a substrate for Ero1. It has previously been shown that the oxidation state of ERp57 is not altered in cells overexpressing Ero1 and that no mixed disulphides are formed between ERp57
and Ero1, leading to the conclusion that ERp57 is not a substrate for Ero1 (12) .
ERp57 is an abundant ER oxidoreductase that is a member of the PDI family of proteins, but is distinct in that it associates with calnexin and calreticulin and has been postulated specifically to be involved in disulphide bond formation in glycoproteins substrates (27) . We also looked at the redox state of ERp57 and found that it is reduced both in the untransfected and Ero1 overexpressing cell-line (SC and NJB unpublished results). The protein we used in this study is a glycoprotein and interacts with calnexin (28) , however the fact that Ero1 overexpression effects disulphide bond formation would suggest that PDI rather than ERp57 is involved in at least the 
